Uncover key drivers, emerging technologies, and competitive movements shaping the cardiac biomarkers testing market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Cardiac Biomarkers Testing Market?
The market size for cardiac biomarkers testing has seen rapid expansion in recent years. This market is projected to expand, reaching $16.7 billion in 2026 from $14.95 billion in 2025, driven by a compound annual growth rate (CAGR) of 11.7%. Factors contributing to its historical growth include a heightened incidence of cardiovascular diseases, improved awareness regarding cardiac health, breakthroughs in laboratory diagnostics, the expansion of hospital infrastructure, and increased government healthcare initiatives.
The cardiac biomarkers testing market size is anticipated to experience substantial growth over the next few years, with projections indicating an expansion to $25.92 billion by 2030, achieving a compound annual growth rate (CAGR) of 11.6%. This predicted growth during the forecast period is fueled by several factors, including the increasing adoption of AI in diagnostics, the expansion of home-based and remote monitoring systems, the progression of precision medicine, the creation of multi-biomarker panels, and a rising demand for real-time cardiac monitoring. Prominent trends expected in this period involve the wider acceptance of point-of-care testing, the development of miniaturized and portable diagnostic devices, advancements in biomarker multiplexing technologies, the evolution of personalized cardiac risk profiling, and the integration of wearables for effective cardiac monitoring.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9436&type=smp
What Drivers Are Supporting Technological Adoption In The Cardiac Biomarkers Testing Market?
The rising prevalence of cardiovascular diseases is projected to stimulate the expansion of the cardiac biomarkers testing market in the future. Cardiovascular disease refers to medical conditions impacting the heart or blood vessels. Cardiac biomarker tests are instrumental in measuring biomarker levels to promptly determine the intensity and scale of a heart attack. Consequently, an increase in the incidence of cardiovascular diseases will drive greater demand for cardiac biomarker testing solutions. For example, in January 2024, the American Heart Association, a US-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease climbed to 233.3 per 100,000 in 2024, an increase of 4.0% from 224.4 per 100,000 in 2023. Therefore, the growing prevalence of cardiovascular diseases is a key factor driving the growth of the cardiac biomarkers testing market.
Which Segments Are Contributing To The Growth Of The Cardiac Biomarkers Testing Market?
The cardiac biomarkers testing market covered in this report is segmented –
1) By Biomarkers Type: Creatine Kinase (CK-MB), Troponins, Myoglobin, Natriuretic Peptides (BNP And NT-proBNP), Ischemia Modified Albumin (IMA), Other Biomarkers Types
2) By Application: Congestive Heart Failure, Acute Coronary Syndrome, Myocardial Infarction, Atherosclerosis, Other Applications
3) By End-User: Hospitals, Specialty Clinics
Which Competitive Trends Are Impacting The Structure Of The Cardiac Biomarkers Testing Market?
Key companies operating within the cardiac biomarker testing market are establishing strategic collaborations to deliver technology designed for detecting early indications of heart conditions and improving patient outcomes. These strategic partnerships in cardiac biomarker testing foster inter-company cooperation, enabling the development of innovative diagnostics, expanding market reach, and accelerating the availability of advanced testing solutions for enhanced cardiovascular care. For instance, in September 2024, MediBuddy, an Indian-based healthcare technology company that provides a comprehensive platform for telehealth services, health management, and insurance assistance, entered into a partnership with Philips, a Netherlands-based conglomerate corporation. Through this alliance, they aim to improve cardiac care in India by integrating Philips’ HeartPrint technology, which allows for regular monitoring and risk assessment of heart health. This forward-looking method provides users with sophisticated tools on the MediBuddy platform, promoting proactive management of heart health and leading to better outcomes.
Who Are The Major Companies Operating In The Cardiac Biomarkers Testing Market?
Major companies operating in the cardiac biomarkers testing market are Abbott Laboratories, Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Biomérieux SA, Becton Dickinson and Company, Randox Laboratories Ltd., Enzo Biochem Inc., Creative Diagnostics Inc., Merck Co. & KGaA, Beckman Coulter Inc., QIAGEN N.V., PerkinElmer Inc., Tosoh Corporation, Eurolyser Diagnostica GmbH, Cortez Diagnostics Inc., DIALAB GmbH, CardioGenics Holdings Inc., Lepu Medical Technology (Beijing) Co. Ltd., Biosynex SA, Charles River Laboratories, Quidel Corporation, Life Diagnostics, Trinity Biotech plc, Guangzhou Wondfo Biotech Co. Ltd., Nova Biomedical Corp., Ortho Clinical Diagnostics Inc., Sekisui Diagnostics Inc., Abcam plc, Bio-Techne Corporation
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Which Region Is Anticipated To See The Fastest Growth In The Cardiac Biomarkers Testing Market?
North America was the largest region in the cardiac biomarkers testing market in 2025. The regions covered in the cardiac biomarkers testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Cardiac Biomarkers Testing Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=9436&type=smp
Browse Through More Reports Similar to the Global Cardiac Biomarkers Testing Market 2026, By The Business Research Company
Cardiac Biomarkers Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-testing-global-market-report
Cardiac Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/cardiac-biomarkers-global-market-report
Clinical Biomarkers Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model